Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Alcoholism

Free Subscription Articles published in PLoS One Retrieve available abstracts of 128 articles: HTML format

Single Articles

January 2025
1. DABA C, Debela SA, Gasheya KA, Endawkie A, et al
   Spatial variation and determinant factors of alcohol consumption in Ethiopia: Spatial and multilevel analysis of Ethiopian demographic and health survey.
   PLoS One. 2025;20:e0309943.
   PubMed     Abstract available
   
   
   
2. CARD-GOWERS J, Boniface S, Brown J, Kock L, et al
   Long-term health consequences and costs of changes in alcohol consumption in England during the COVID-19 pandemic.
   PLoS One. 2025;20:e0314870.
   PubMed     Abstract available
   
   
   
3. KIM M, Jun BG, Shin HS, Yi JJ, et al
   Impact of high body mass index on hepatocellular carcinoma risk in chronic liver disease: A population-based prospective cohort study.
   PLoS One. 2025;20:e0316175.
   PubMed     Abstract available
   
   
   
4. TOVMASYAN A, Monk RL, Heim D
   Correction: Towards an affect intensity regulation hypothesis: Systematic review and meta-analyses of the relationship between affective states and alcohol consumption.
   PLoS One. 2025;20:e0318674.
   PubMed     Abstract available
   
   
   
5. FARNIA V, Mohebian M, Davarinejad O, A Hien D, et al
   Alcohol consumption associated with suicidal ideation, and suicide attempts in substance users: A cross-sectional study of an addiction registry in western Iran.
   PLoS One. 2025;20:e0317456.
   PubMed     Abstract available
   
   
   
6. XUE J, Zhao L, Shao L, Zhang H, et al
   Higher risk of carotid plaque among lean individuals with non-alcoholic fatty liver disease: A retrospective study.
   PLoS One. 2025;20:e0316997.
   PubMed     Abstract available
   
   
   
7. GHAIMO FE, Mzilangwe ES, Chacha S, Kuganda SB, et al
   Prevalence and factors associated with alcohol use disorders among people living with HIV attending care and treatment centers at Kilimanjaro, Tanzania: A cross-sectional study.
   PLoS One. 2025;20:e0318120.
   PubMed     Abstract available
   
   
   
8. LEME RD, Maranon-Vasquez GA, Goncalves JL, de Carvalho FK, et al
   Effect of prenatal alcohol consumption on dental enamel formation in offspring-An animal study protocol.
   PLoS One. 2025;20:e0317570.
   PubMed     Abstract available
   
   
   
9. CHO EH, Kim JA, Park MS, Kwon MJ, et al
   Mean platelet volume as a biomarker for liver fibrosis in patients with Non-alcoholic fatty liver disease.
   PLoS One. 2025;20:e0318847.
   PubMed     Abstract available
   
   
   
10. ROSENBERG N, Buono M, Ndebwanimana V, Niyonzima J, et al
    Adaptation and validation of a Rwanda-focused version of the Alcohol Use Disorder Identification Test (AUDIT).
    PLoS One. 2025;20:e0316993.
    PubMed     Abstract available
    
    
    
11. SKLADANY L, Zilincanova D, Zilincan M, Okapec S, et al
    Hepatic venous pressure gradient in patients with (compensated and decompensated) advanced chronic liver disease - A comparison of metabolic dysfunction-associated steatotic liver disease with alcohol-associated liver disease: A retrospective view.
    PLoS One. 2025;20:e0317287.
    PubMed     Abstract available
    
    
    
12. ZELLNER T, Metzger JC, Bekka E, Rabaioli M, et al
    Emergency admission, previous delirium tremens and increased liver stiffness as risk factors for severe alcohol withdrawal - A prospective study.
    PLoS One. 2025;20:e0320083.
    PubMed     Abstract available
    
    
    
13. YU N, Gordon D, Zou H, Chen Y, et al
    Developmental trajectory of voluntary alcohol consumption in adolescent mice using finite mixture modeling and Bayesian posterior probability analysis.
    PLoS One. 2025;20:e0321506.
    PubMed     Abstract available
    
    
    
14. HUANG Y, Ao T, Wang Y, Zhen P, et al
    The red blood cell distribution width is associated with all-cause and cardiovascular mortality among individuals with non-alcoholic fatty liver disease.
    PLoS One. 2025;20:e0321789.
    PubMed     Abstract available
    
    
    
15. BASA M, De Vries J, McDonagh D, Comiskey C, et al
    Adherence to alcohol consumption-related recommendations and predictors of heavy episodic drinking among patients with NCDs during the COVID-19 pandemic.
    PLoS One. 2025;20:e0321577.
    PubMed     Abstract available
    
    
    
16. LUQUIENS A, Panjo H, Dereux A, Louville P, et al
    AQoLS-Brief: Development and psychometric properties of a short version of the alcohol quality of life scale.
    PLoS One. 2025;20:e0321365.
    PubMed     Abstract available
    
    
    
17. YANG J, Zhou Z
    Analysis and study of risk factors related to the progression of non-alcoholic fatty liver disease: A retrospective cohort study.
    PLoS One. 2025;20:e0322990.
    PubMed     Abstract available
    
    
    
18. NAVARRO-HARO MV, Abanades-Morillo A, Peris-Baquero O, Martinez-Borba V, et al
    Implementation of two transdiagnostic interventions based on emotional regulation for professionals who treat alcohol addiction in the Spanish mental health system: A multicenter mixed methods pilot study protocol.
    PLoS One. 2025;20:e0318512.
    PubMed     Abstract available
    
    
    
19. MAUDUY M, Maurage P, Mauny N, Pitel AL, et al
    Predictors of alcohol use disorder risk in young adults: Direct and indirect psychological paths through binge drinking.
    PLoS One. 2025;20:e0321974.
    PubMed     Abstract available
    
    
    
20. PHILIBERT R, Beach SRH, Mills JA, Dawes K, et al
    Epigenetic assessments of alcohol consumption predict mortality in smokers at risk for lung cancer in the prostate, lung, colorectal and ovarian cancer screening trial.
    PLoS One. 2025;20:e0322783.
    PubMed     Abstract available
    
    
    
21. LUANGSINSIRI C, Thavorncharoensap M, Chaikledkaew U, Pattanaprateep O, et al
    What is the lifetime cost of alcohol consumption? an estimation of economic burden in Thailand.
    PLoS One. 2025;20:e0322944.
    PubMed     Abstract available
    
    
    
22. JIANG H, Qin C, Xu YM
    Feasibility of shear wave elastography for assessing steatosis in early-stage non-alcoholic fatty liver disease.
    PLoS One. 2025;20:e0324637.
    PubMed     Abstract available
    
    
    
23. KULJANCIC D, Amidzic J, Ljubotin L, Siladji D, et al
    Clinical profile of alcohol dependent paintents according to Lesch Typology one year after the Covid-19 pandemic-comparative study.
    PLoS One. 2025;20:e0324851.
    PubMed     Abstract available
    
    
    
24. JOE H, Oh JE, Cho YJ, Shin HS, et al
    Association between smoking status and non-alcoholic fatty liver disease.
    PLoS One. 2025;20:e0325305.
    PubMed     Abstract available
    
    
    
25. QU X, Jiang J
    Osteoporosis is associated with increased CVD mortality and all-cause mortality in alcohol-consuming individuals: A cohort study using data from NHANES.
    PLoS One. 2025;20:e0327180.
    PubMed     Abstract available
    
    
    
26. HUANG S, Hu W, Fang T
    The global impact of non-alcoholic fatty liver disease (including cirrhosis) in the elderly from 1990 to 2021 and future projections of disease burden.
    PLoS One. 2025;20:e0325961.
    PubMed     Abstract available
    
    
    
27. LLORET TORRES ME, Rivas Jimenez A, Tosado Rodriguez EL, Cardona Jordan K, et al
    Comparative mRNA profile analysis from NAc of adolescent male mice after binge-like alcohol exposure eliciting deficits in context fear extinction learning.
    PLoS One. 2025;20:e0322576.
    PubMed     Abstract available
    
    
    
28. BAZMI S, Parvaneh T, Mohammadi Z, Pishdad P, et al
    Association of prior opium addiction with incident non-alcoholic fatty liver disease: A case-control study.
    PLoS One. 2025;20:e0326889.
    PubMed     Abstract available
    
    
    
29. LEE EH, Seo MH, Park SY, Mukherjee S, et al
    A novel yeast-derived aldehyde-reducing compound MF001 protects against alcohol-induced liver damage.
    PLoS One. 2025;20:e0327648.
    PubMed     Abstract available
    
    
    
30. LI L, Zhang Y, Leng J, Li S, et al
    The global, regional and national burden of pancreatitis due to alcohol use: Results from the Global Burden of Disease Study 2021 and projections to 2040.
    PLoS One. 2025;20:e0327831.
    PubMed     Abstract available
    
    
    
31. GUPTA R, Pawliuk C, Somuah-Asamoah D, Boerner KE, et al
    How do the neurocognitive profiles of FASD and complex trauma compare in the pediatric population?: A scoping review protocol.
    PLoS One. 2025;20:e0328845.
    PubMed     Abstract available
    
    
    
32. WELFORDSSON P, Danielsson AK, Bjorck C, Grzymala-Lubanski B, et al
    Alcohol use as a modifiable risk factor in cardiology: A qualitative study of patient perspectives in Sweden.
    PLoS One. 2025;20:e0328990.
    PubMed     Abstract available
    
    
    
33. 
    Correction: Steatosis is involved in the progression of kidney disease in a high-fat-diet-induced non-alcoholic steatohepatitis mouse model.
    PLoS One. 2025;20:e0329654.
    PubMed     Abstract available
    
    
    
34. CAMPANELLA S, Dubuson M, Pereira M, Mouras H, et al
    Investigating approach/avoidance tendencies in male AUD patients through a gait initiation task: An exploratory posturography study.
    PLoS One. 2025;20:e0327765.
    PubMed     Abstract available
    
    
    
35. O'NEILL J, Joshi S, Alger JR, Leuchter AF, et al
    Trigeminal nerve stimulation (TNS) for children with attention deficit/hyperactivity disorder and fetal alcohol spectrum disorder: Feasibility study protocol.
    PLoS One. 2025;20:e0330986.
    PubMed     Abstract available
    
    
    
36. JU N, Zhao Y, Liang Y, Liang Y, et al
    The interaction between candidate SNPs and social factors significantly influences the prevalence of alcohol use disorder in Chinese young male adults.
    PLoS One. 2025;20:e0330822.
    PubMed     Abstract available
    
    
    
37. 
    Correction: What is the lifetime cost of alcohol consumption? An estimation of economic burden in Thailand.
    PLoS One. 2025;20:e0331594.
    PubMed     Abstract available
    
    
    
38. BAGI O, Kadar BK, Farkas FF, Gajdics J, et al
    The role of kindling mechanism: A validation study of the Hungarian version of the Prediction of Alcohol Withdrawal Severity Scale.
    PLoS One. 2025;20:e0330629.
    PubMed     Abstract available
    
    
    
39. ZHU J, Chen Y, Han Y, Li J, et al
    Mechanism of Huanglian Wendan Decoction in ameliorating non-alcoholic fatty liver disease via modulating gut microbiota-mediated metabolic reprogramming and activating the LKB1/AMPK pathway.
    PLoS One. 2025;20:e0331303.
    PubMed     Abstract available
    
    
    
40. MULLER-KUHNLE J, Schanz M, Schricker S, Benignus C, et al
    Predicting severe renal dysfunction in alcohol-associated cirrhosis: Comparative performance of liver function scores and machine learning models.
    PLoS One. 2025;20:e0332840.
    PubMed     Abstract available
    
    
    
41. DAVIES N, Charalampopoulos D, Rose A, Messahel S, et al
    Identifying and describing alcohol-related paediatric emergency department attendances amongst under 16 year olds including time trends, incidence rates, and sociodemographic factors associated with alcohol-related harm.
    PLoS One. 2025;20:e0329502.
    PubMed     Abstract available
    
    
    
42. TATARI F, Alikhani M, Radmehr F, Hookari S, et al
    Estimating the prevalence alcohol use disorder and relapse risks in Kermanshah Province of Iran: Integrating direct, indirect methods, and tree-based analysis.
    PLoS One. 2025;20:e0325107.
    PubMed     Abstract available
    
    
    
43. YUAN J, Chen Z, Gu Y, Liang Y, et al
    Effects of alcohol consumption on the prevalence and incidence of non-alcoholic fatty liver disease: A systematic review and meta-analysis.
    PLoS One. 2025;20:e0330105.
    PubMed     Abstract available
    
    
    
44. SUTTAWONG N, Witayavanitkul N, Chayanupatkul M, Wanpiyarat N, et al
    Gardenia jasminoides fruit extract ameliorates non-alcoholic steatohepatitis with fibrosis by modulating inflammatory and fibrogenic pathways.
    PLoS One. 2025;20:e0333800.
    PubMed     Abstract available
    
    
    
45. LAU BK, Emmons K, Maddox RK, Estes A, et al
    The relationship between intellectual ability and auditory multitalker speech perception in neurodivergent individuals.
    PLoS One. 2025;20:e0329581.
    PubMed     Abstract available
    
    
    January 2024
46. POWELL A, Sumnall H, Smith J, Kuiper R, et al
    Recovery of neuropsychological function following abstinence from alcohol in adults diagnosed with an alcohol use disorder: Systematic review of longitudinal studies.
    PLoS One. 2024;19:e0296043.
    PubMed     Abstract available
    
    
    
47. DE BEJCZY A, Lido H, Soderpalm B
    A randomized, double-blind, placebo-controlled, multicentre trial on the efficacy of varenicline and bupropion in combination and alone for treatment of alcohol use disorder: Protocol for the COMB study.
    PLoS One. 2024;19:e0296118.
    PubMed     Abstract available
    
    
    
48. PARADA S, Rubio B, Taschini E, Laqueille X, et al
    Creating a psychosocial intervention combining growth mindset and implementation intentions (GMII) to reduce alcohol consumption: A mixed method approach.
    PLoS One. 2024;19:e0297647.
    PubMed     Abstract available
    
    
    
49. SUHAG A, Webb TL, Holmes J
    Longitudinal clustering of health behaviours and their association with multimorbidity in older adults in England: A latent class analysis.
    PLoS One. 2024;19:e0297422.
    PubMed     Abstract available
    
    
    
50. KHALIFA A, Palu R, Perkins AE, Volz A, et al
    Prenatal alcohol exposure alters expression of genes involved in cell adhesion, immune response, and toxin metabolism in adolescent rat hippocampus.
    PLoS One. 2024;19:e0293425.
    PubMed     Abstract available
    
    
    
51. MCCABE EM, Luk JW, Stangl BL, Schwandt ML, et al
    Exercising healthy behaviors: A latent class analysis of positive coping during the COVID-19 pandemic and associations with alcohol-related and mental health outcomes.
    PLoS One. 2024;19:e0297060.
    PubMed     Abstract available
    
    
    
52. NAIRZ J, Messner A, Kiechl SJ, Winder B, et al
    Determinants of non-alcoholic fatty liver disease in young people: Maternal, neonatal, and adolescent factors.
    PLoS One. 2024;19:e0298800.
    PubMed     Abstract available
    
    
    
53. TSUI JI, Rossi SL, Cheng DM, Bendiks S, et al
    Pilot RCT comparing low-dose naltrexone, gabapentin and placebo to reduce pain among people with HIV with alcohol problems.
    PLoS One. 2024;19:e0297948.
    PubMed     Abstract available
    
    
    
54. ELGUEZABAL RODELO RG, Porchia LM, Torres-Rasgado E, Lopez-Bayghen E, et al
    Visceral and subcutaneous abdominal fat is associated with non-alcoholic fatty liver disease while augmenting Metabolic Syndrome's effect on non-alcoholic fatty liver disease: A cross-sectional study of NHANES 2017-2018.
    PLoS One. 2024;19:e0298662.
    PubMed     Abstract available
    
    
    
55. NILSSON AH, Schwartz HA, Rosenthal RN, McKay JR, et al
    Language-based EMA assessments help understand problematic alcohol consumption.
    PLoS One. 2024;19:e0298300.
    PubMed     Abstract available
    
    
    
56. THOMAS S, Schafer J, Kanske P, Trautmann S, et al
    Patterns of social-affective responses to trauma exposure and their relation to psychopathology.
    PLoS One. 2024;19:e0289664.
    PubMed     Abstract available
    
    
    
57. TUMWEGAMIRE A, Fatch R, Emenyonu NI, Lodi S, et al
    Association between smoking and lack of HIV virological suppression in a cross-sectional study of persons with HIV on antiretroviral therapy in Uganda.
    PLoS One. 2024;19:e0300508.
    PubMed     Abstract available
    
    
    
58. CAI W, Qiu T, Hu W, Fang T, et al
    Changes in the intestinal microbiota of individuals with non-alcoholic fatty liver disease based on sequencing: An updated systematic review and meta-analysis.
    PLoS One. 2024;19:e0299946.
    PubMed     Abstract available
    
    
    
59. POPOVA S, Dozet D, Temple V, McFarlane A, et al
    Fetal alcohol spectrum disorder diagnostic clinic capacity in Canadian Provinces and territories.
    PLoS One. 2024;19:e0301615.
    PubMed     Abstract available
    
    
    
60. FARNIA V, Ahmadi Jouybari T, Salemi S, Moradinazar M, et al
    The prevalence of alcohol consumption and its related factors in adolescents: Findings from Global School-based Student Health Survey.
    PLoS One. 2024;19:e0297225.
    PubMed     Abstract available
    
    
    
61. SHCHETININA A, Slopen N
    Unmet need for alcohol use disorder treatment in reproductive-age females, with emphasis on pregnant and parenting populations in the United States: Findings from NSDUH 2015-2021.
    PLoS One. 2024;19:e0301810.
    PubMed     Abstract available
    
    
    
62. CHAVEZ-TAPIA NC, Sanchez-Jimenez BA, Vidana-Perez D, Corrales-Rosas B, et al
    Predictors for liver fibrosis in non-alcoholic patients with psoriatic diseases: A multicenter cross sectional-study.
    PLoS One. 2024;19:e0290632.
    PubMed     Abstract available
    
    
    
63. JOSE R, Wang W, Sherman G, Rosenthal RN, et al
    Tapping into alcohol use during COVID: Drinking correlates among bartenders and servers.
    PLoS One. 2024;19:e0300932.
    PubMed     Abstract available
    
    
    
64. LIN YH, Zhang ZJ, Zhong JQ, Wang ZY, et al
    Semaglutide combined with empagliflozin vs. monotherapy for non-alcoholic fatty liver disease in type 2 diabetes: Study protocol for a randomized clinical trial.
    PLoS One. 2024;19:e0302155.
    PubMed     Abstract available
    
    
    
65. HAVLIK JL, Rhee TG, Rosenheck RA
    Association of mental health related quality of life and other factors with treatment seeking for substance use disorders: A comparison of SUDs rooted in legal, partially legal, and illegal substances.
    PLoS One. 2024;19:e0302544.
    PubMed     Abstract available
    
    
    
66. FUNUYET-SALAS J, Martin-Rodriguez A, Perez-San-Gregorio MA, Vale L, et al
    Health-related quality of life in non-alcoholic fatty liver disease: A cross-cultural study between Spain and the United Kingdom.
    PLoS One. 2024;19:e0300362.
    PubMed     Abstract available
    
    
    
67. GRIMES KEL, Ebasone PV, Dzudie A, Nash D, et al
    Intimate partner violence, depression, hazardous alcohol use, and social support among people with HIV initiating HIV care in Cameroon.
    PLoS One. 2024;19:e0304114.
    PubMed     Abstract available
    
    
    
68. KESSEL K, Forsblom E, Ruotsalainen E, Jarvinen A, et al
    Staphylococcus aureus bacteremia in alcoholics.
    PLoS One. 2024;19:e0298612.
    PubMed     Abstract available
    
    
    
69. KRAMER T, Groh G, Stuben N, Soyka M, et al
    Analysis of addiction craving onset through natural language processing of the online forum Reddit.
    PLoS One. 2024;19:e0301682.
    PubMed     Abstract available
    
    
    
70. TEVIK K, Skrastad RB, Benth JS, Selbaek G, et al
    Prevalence and change in alcohol consumption in older adults over time, assessed with self-report and Phosphatidylethanol 16:0/18:1 -The HUNT Study.
    PLoS One. 2024;19:e0304714.
    PubMed     Abstract available
    
    
    
71. PIACENTINO D, Vizioli C, Barb JJ, Grant-Beurmann S, et al
    Gut microbial diversity and functional characterization in people with alcohol use disorder: A case-control study.
    PLoS One. 2024;19:e0302195.
    PubMed     Abstract available
    
    
    
72. ABIRI P, Jeong ISD, Verdell A, Shah S, et al
    Improvement in inpatient discharge planning for patients with alcohol use disorder with the implementation of a team-based multidisciplinary workflow.
    PLoS One. 2024;19:e0306066.
    PubMed     Abstract available
    
    
    
73. BEYNA AT, Mengesha AK, Yefter ET, Kahaliw W, et al
    Evaluation of wound healing and anti-inflammatory activity of hydro-alcoholic extract and solvent fractions of the leaves of Clerodendrum myricoides (Lamiaceae) in mice.
    PLoS One. 2024;19:e0306766.
    PubMed     Abstract available
    
    
    
74. YOUNG AS, Reboussin BA, Riehm K, Mojtabai R, et al
    Associations between mental health & substance use treatment and alcohol use progression and recovery among US women drinkers.
    PLoS One. 2024;19:e0306820.
    PubMed     Abstract available
    
    
    
75. SHI Y, Zhang J, Wang Z, Shan F, et al
    The association between alcohol consumption and herpes simplex virus type 2: A cross-sectional study from national health and nutrition examination survey 2009-2016.
    PLoS One. 2024;19:e0307702.
    PubMed     Abstract available
    
    
    
76. KIM CR, Kim SY, Kim J, Park EC, et al
    Association between sleep patterns and alcohol use disorders in workers.
    PLoS One. 2024;19:e0308418.
    PubMed     Abstract available
    
    
    
77. ROGES J, Bosque-Prous M, Folch C, Teixido-Compano E, et al
    Effects of social and environmental restrictions, and changes in alcohol availability in adolescents' binge drinking during the COVID-19 pandemic.
    PLoS One. 2024;19:e0309320.
    PubMed     Abstract available
    
    
    
78. JEREMIAH RP, Katisi M, Shehu OM
    Alcohol misuse within different socio-ecologies in rural communities of Botswana.
    PLoS One. 2024;19:e0306542.
    PubMed     Abstract available
    
    
    
79. SANCERNI-BEITIA MD, Motos-Selles P, Gimenez-Costa JA, Cortes-Tomas MT, et al
    A short version of the Alcohol Consumption Consequences Evaluation Scale (ACCE10).
    PLoS One. 2024;19:e0308918.
    PubMed     Abstract available
    
    
    
80. GOMA M, Ng'ambi WF, Zyambo C
    Predicting harmful alcohol use prevalence in Sub-Saharan Africa between 2015 and 2019: Evidence from population-based HIV impact assessment.
    PLoS One. 2024;19:e0301735.
    PubMed     Abstract available
    
    
    
81. JAIN JP, Ma Y, Dawson-Rose C, Santos GM, et al
    The prevalence and correlates of biomarker positive unhealthy alcohol use among women living with and without HIV in San Francisco, California.
    PLoS One. 2024;19:e0308867.
    PubMed     Abstract available
    
    
    
82. TEKLU SW, Kotola BS, Alemneh HT
    Smoking and alcoholism dual addiction dissemination model analysis with optimal control theory and cost-effectiveness.
    PLoS One. 2024;19:e0309356.
    PubMed     Abstract available
    
    
    
83. GARLAND C, Abdulla N, Lee D, Spiwak R, et al
    The impact of alcohol misuse in trauma patients: A scoping review protocol.
    PLoS One. 2024;19:e0301241.
    PubMed     Abstract available
    
    
    
84. LI J, Zhou Z, Gao G, Zang L, et al
    Effectiveness of exercise intervention in improving physical and mental status of patients with alcohol use disorders: A systematic review and meta-analysis.
    PLoS One. 2024;19:e0311166.
    PubMed     Abstract available
    
    
    
85. DONG J, Li Z, Wang C, Zhang R, et al
    Dietary folate intake and all-cause mortality and cardiovascular mortality in American adults with non-alcoholic fatty liver disease: Data from NHANES 2003 to 2018.
    PLoS One. 2024;19:e0314148.
    PubMed     Abstract available
    
    
    
86. SAMBO D, Kinstler E, Lin Y, Goldman D, et al
    Differential effects of prenatal alcohol exposure on brain growth reveals early upregulation of cell cycle and apoptosis and delayed downregulation of metabolism in affected offspring.
    PLoS One. 2024;19:e0311683.
    PubMed     Abstract available
    
    
    
87. GIL-ALANA LA, Lopez G, Hernandez-Herrera M
    Alcohol consumption in the G7 countries (1960-2021). Permanent versus transitory shocks.
    PLoS One. 2024;19:e0314877.
    PubMed     Abstract available
    
    
    
88. FLANNIGAN K, Edwards DC, Reid D, McFarlane A, et al
    Caregiver approaches, resiliencies, and experiences raising individuals with fetal alcohol spectrum disorder: A study protocol paper.
    PLoS One. 2024;19:e0312692.
    PubMed     Abstract available
    
    
    
89. TAN MG, Wider W, Pang NTP, Lasimbang HB, et al
    Gendered narratives and cultural shifts: A qualitative study on decadal changes in community alcohol consumption.
    PLoS One. 2024;19:e0309378.
    PubMed     Abstract available
    
    
    
90. WANG S, Lu K, Lin L, Li G, et al
    Exploring the mechanism of berberine treatment for atherosclerosis combined with non-alcoholic fatty liver disease based on bioinformatic and experimental study.
    PLoS One. 2024;19:e0314961.
    PubMed     Abstract available
    
    
    
91. KE T, Livingston M, Zhang Y, Pavlyshyn D, et al
    A longitudinal study of alcohol consumption among adults in Victoria, Australia during the COVID-19 pandemic.
    PLoS One. 2024;19:e0313599.
    PubMed     Abstract available
    
    
    January 2023
92. BUTLER JL, Gordon-Larsen P, Steffen LM, Shikany JM, et al
    Associations of 5-year changes in alcoholic beverage intake with 5-year changes in waist circumference and BMI in the Coronary Artery Risk Development in Young Adults (CARDIA) study.
    PLoS One. 2023;18:e0281722.
    PubMed     Abstract available
    
    
    
93. JEONG W
    Comparison of alcohol consumption and tobacco use among Korean adolescents before and during the COVID-19 pandemic.
    PLoS One. 2023;18:e0283462.
    PubMed     Abstract available
    
    
    
94. YOKOYAMA A, Kimura M, Yoshimura A, Matsushita S, et al
    Nonsmoking after simultaneous alcohol abstinence and smoking cessation program was associated with better drinking status outcome in Japanese alcohol-dependent men: A prospective follow-up study.
    PLoS One. 2023;18:e0282992.
    PubMed     Abstract available
    
    
    
95. MATULYTE E, Davidaviciene E, Kancauskiene Z, Diktanas S, et al
    The socio-demographic, clinical characteristics and outcomes of tuberculosis among HIV infected adults in Lithuania: A thirteen-year analysis.
    PLoS One. 2023;18:e0282046.
    PubMed     Abstract available
    
    
    
96. SKRZYNSKI CJ, Creswell KG
    Solitary-specific drinking to cope motives explain unique variance in solitary drinking behavior but not alcohol problems compared to general drinking to cope motives.
    PLoS One. 2023;18:e0282506.
    PubMed     Abstract available
    
    
    
97. MONK RL, Qureshi AW, Richardson GB, Heim D, et al
    UK alcohol consumption during the COVID-19 pandemic: The role of drinking motives, employment and subjective mental health.
    PLoS One. 2023;18:e0283233.
    PubMed     Abstract available
    
    
    
98. GILBERT PA, Soweid L, Holdefer PJ, Kersten S, et al
    Strategies to maintain recovery from alcohol problems during the COVID-19 pandemic: Insights from a mixed-methods national survey of adults in the United States.
    PLoS One. 2023;18:e0284435.
    PubMed     Abstract available
    
    
    
99. FUENTES-BEALS C, Olivares-Costa M, Andres ME, Haeger PA, et al
    Bioinformatic analysis predicts that ethanol exposure during early development causes alternative splicing alterations of genes involved in RNA post-transcriptional regulation.
    PLoS One. 2023;18:e0284357.
    PubMed     Abstract available
    
    
    
100. LADI-AKINYEMI T', Okpue AP, Onigbinde OA, Okafor IP, et al
     Depression and suicidal ideation among undergraduates in state tertiary institutions in Lagos Nigeria.
     PLoS One. 2023;18:e0284955.
     PubMed     Abstract available
     
     
     
101. GENTRY AE, Alexander JC, Ahangari M, Peterson RE, et al
     Case-only exome variation analysis of severe alcohol dependence using a multivariate hierarchical gene clustering approach.
     PLoS One. 2023;18:e0283985.
     PubMed     Abstract available
     
     
     
102. BUYCO DG, Dempsey JL, Scorletti E, Jeon S, et al
     Concomitant western diet and chronic-binge alcohol dysregulate hepatic metabolism.
     PLoS One. 2023;18:e0281954.
     PubMed     Abstract available
     
     
     
103. KANG SJ, Pei CZ, Lee DH, Ha JE, et al
     A pilot randomized clinical trial of biomedical link with mental health in art therapy intervention programs for alcohol use disorder: Changes in NK cells, addiction biomarkers, electroencephalography, and MMPI-2 profiles.
     PLoS One. 2023;18:e0284344.
     PubMed     Abstract available
     
     
     
104. JACKSON SE, Cox S, Shahab L, Brown J, et al
     Impact of the cost-of-living crisis on the nature of attempts to stop smoking and to reduce alcohol consumption in Great Britain: A representative population survey, 2021-2022.
     PLoS One. 2023;18:e0286183.
     PubMed     Abstract available
     
     
     
105. MITROVIC N, Sabanovic M, Vujovic A, Jovanovic J, et al
     Influence of chronic liver diseases on the course and outcome of COVID-19.
     PLoS One. 2023;18:e0288350.
     PubMed     Abstract available
     
     
     
106. BRADSHAW D, Abramowicz I, Bremner S, Verma S, et al
     Hepmarc: A 96 week randomised controlled feasibility trial of add-on maraviroc in people with HIV and non-alcoholic fatty liver disease.
     PLoS One. 2023;18:e0288598.
     PubMed     Abstract available
     
     
     
107. KRUGER K, Oedingen C, Kautz A, Langenbacher D, et al
     Lifestyle interventions for patients with non-alcoholic steato-hepatitis-Design, rationale and protocol of the study "target group-specific optimisation of lifestyle interventions for behavior change in non-alcoholic steato-hepatitis (OPTI-NASH)".
     PLoS One. 2023;18:e0288905.
     PubMed     Abstract available
     
     
     
108. EVERETT RA, Lewis AL, Kuerbis A, Peace A, et al
     Data driven mixed effects modeling of the dual process framework of addiction among individuals with alcohol use disorder.
     PLoS One. 2023;18:e0265168.
     PubMed     Abstract available
     
     
     
109. CHANDRA R, Srivastava S, Singh A, Mukherjee S, et al
     Locating perpetrators of violence against women in India: An analysis of married men's characteristics associated with intimate partner violence.
     PLoS One. 2023;18:e0289596.
     PubMed     Abstract available
     
     
     
110. STATON CA, Friedman K, Phillips AJ, Minnig MC, et al
     Feasibility of a pragmatic randomized adaptive clinical trial to evaluate a brief negotiational interview for harmful and hazardous alcohol use in Moshi, Tanzania.
     PLoS One. 2023;18:e0288458.
     PubMed     Abstract available
     
     
     
111. PESTI-ASBOTH G, Szilagyi E, Birone Molnar P, Olah J, et al
     Monitoring physiological processes of fast-growing broilers during the whole life cycle: Changes of redox-homeostasis effected to trassulfuration pathway predicting the development of non-alcoholic fatty liver disease.
     PLoS One. 2023;18:e0290310.
     PubMed     Abstract available
     
     
     
112. BLAKE H, Yildirim M, Premakumar V, Morris L, et al
     Attitudes and current practice in alcohol screening, brief intervention, and referral for treatment among staff working in urgent and emergency settings: An open, cross-sectional international survey.
     PLoS One. 2023;18:e0291573.
     PubMed     Abstract available
     
     
     
113. AKWA LG, Smith L, Twiddy M, Abt G, et al
     Associations between physical activity, sedentary behaviour, and alcohol consumption among UK adults: Findings from the Health Behaviours during the COVID-19 pandemic (HEBECO) study.
     PLoS One. 2023;18:e0287199.
     PubMed     Abstract available
     
     
     
114. HUANG Q, Guo J, Zhao H, Zheng Y, et al
     The associations of alcoholic liver disease and nonalcoholic fatty liver disease with bone mineral density and the mediation of serum 25-Hydroxyvitamin D: A bidirectional and two-step Mendelian randomization.
     PLoS One. 2023;18:e0292881.
     PubMed     Abstract available
     
     
     
115. MONTGOMERY C, Saini P, Schoetensack C, McCarthy M, et al
     Improving access to treatment for alcohol dependence in primary care: A qualitative investigation of factors that facilitate and impede treatment access and completion.
     PLoS One. 2023;18:e0292220.
     PubMed     Abstract available
     
     
     
116. CHACON C, Arteaga I, Martinez-Escude A, Ruiz Rojano I, et al
     Clinical epidemiology of non-alcoholic fatty liver disease in children and adolescents. The LiverKids: Study protocol.
     PLoS One. 2023;18:e0286586.
     PubMed     Abstract available
     
     
     
117. GUIMARAES RA, de Morais Neto OL, Dos Santos TMB, Mandacaru PMP, et al
     Impact of the program life in traffic and new zero-tolerance drinking and driving law on the prevalence of driving after alcohol abuse in Brazilian capitals: An interrupted time series analysis.
     PLoS One. 2023;18:e0288288.
     PubMed     Abstract available
     
     
     
118. VISSOCI JRN, Friedman K, Caruzzo NM, de Oliveira LP, et al
     Clinical evaluation of the alcohol use disorders identification test (AUDIT) in Moshi, Tanzania.
     PLoS One. 2023;18:e0287835.
     PubMed     Abstract available
     
     
     
119. WEN W, Guo C, Chen Z, Yang D, et al
     Regular exercise attenuates alcoholic myopathy in zebrafish by modulating mitochondrial homeostasis.
     PLoS One. 2023;18:e0294700.
     PubMed     Abstract available
     
     
     
120. ROUSSON V, Trachsel B, Iglesias K, Baggio S, et al
     Evaluating the cost of simplicity in score building: An example from alcohol research.
     PLoS One. 2023;18:e0294671.
     PubMed     Abstract available
     
     
     
121. PURUSHOTHAMA C, Crape BL, Stolyarov V, Jaxybayeva A, et al
     Preloaded combination nicotine replacement therapy for smoking cessation in Kazakhstan: A randomized controlled trial study protocol.
     PLoS One. 2023;18:e0292490.
     PubMed     Abstract available
     
     
     
122. ZHANG B, Zhang R, Deng H, Cui P, et al
     Research protocol of the efficacy of probiotics for the treatment of alcohol use disorder among adult males: A comparison with placebo and acceptance and commitment therapy in a randomized controlled trial.
     PLoS One. 2023;18:e0294768.
     PubMed     Abstract available
     
     
     
123. SABRI B, Budhathoki C, McFall AM, Mehta SH, et al
     Cumulative violence exposures among men who have sex with men living with HIV in India: Psychosocial correlates of HIV care continuum outcomes.
     PLoS One. 2023;18:e0295225.
     PubMed     Abstract available
     
     
     
124. YOUSSEF L, Salameh P, Sacre H, Akel M, et al
     Association between alexithymia, emotional intelligence, smoking addiction, and alcohol use disorder among a sample of Lebanese adults.
     PLoS One. 2023;18:e0295114.
     PubMed     Abstract available
     
     
     
125. MOUNIKA N, Yadav A, Kamboj P, Banerjee SK, et al
     Circulatory bone morphogenetic protein (BMP) 8B is a non-invasive predictive biomarker for the diagnosis of non-alcoholic steatohepatitis (NASH).
     PLoS One. 2023;18:e0295839.
     PubMed     Abstract available
     
     
     
126. JIA X, Zhang X, Zhou T, Sun D, et al
     Cyp3A4 *1G polymorphism is associated with alcohol drinking: A 5-year retrospective single centered population-based study in China.
     PLoS One. 2023;18:e0295184.
     PubMed     Abstract available
     
     
     
127. PELOSO A, Lacotte S, Gex Q, Slits F, et al
     Portosystemic shunting prevents hepatocellular carcinoma in non-alcoholic fatty liver disease mouse models.
     PLoS One. 2023;18:e0296265.
     PubMed     Abstract available
     
     
     January 2021
128. RODRIGUES R, Lopez-Caneda E, Almeida-Antunes N, Sampaio A, et al
     Portuguese validation of the Alcohol Craving Questionnaire-Short Form-Revised.
     PLoS One. 2021;16:e0251733.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Alcoholism is free of charge.